The offering includes the full integration of the ADC technology platform, which will now be offered by Lonza as part of its advanced synthesis portfolio.

Even as CDMO Lonza deals with FDA concerns about its cell manufacturing operation in the U.S., it has gone out and acquired a gene and cell contract manufacturer in Europe. Lonza said last week that ...

Quote from Jean-Christophe Hyvert, President, Biologics and Cell & Gene, Lonza: 'Once more, we are pleased to leverage our network as we expand our collaboration with Moderna further to extend our ...

(RTTNews) - Covid-19 vaccine maker Moderna Inc. (MRNA) announced Wednesday that it has entered into an additional agreement with Lonza Group AG (LZAGF.PK), a supplier to the pharmaceutical, healthcare ...

ToolGen, a leader in gene editing technology, announced on the 8th that it has filed a patent infringement lawsuit in the Hague District Court in the Netherlands against Lonza Netherlands BV, a global ...

(RTTNews) - Covid-19 vaccine maker Moderna Inc. (MRNA) announced Wednesday that it has entered into an additional agreement with Lonza Group AG (LZAGF.PK), a supplier to the pharmaceutical, healthcare ...

Lawsuit filed against Lonza, the Dutch manufacturer of the world's first CRISPR-based genome editing therapy, CASGEVY Second European action following UK litigation, enforcing ToolGen's rights to ...

SEOUL, South Korea, Sept. 8, 2025 /PRNewswire/ -- ToolGen, Inc. (KOSDAQ: 199800), a global leader in genome editing technology, today announced that it has filed a patent infringement lawsuit against ...